Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M C M Kouwenhoven"'
Autor:
T. Numan, S. D. Kulik, B. Moraal, J. C. Reijneveld, C. J. Stam, P. C. de Witt Hamer, J. Derks, A. M. E. Bruynzeel, M. E. van Linde, P. Wesseling, M. C. M. Kouwenhoven, M. Klein, T. Würdinger, F. Barkhof, J. J. G. Geurts, A. Hillebrand, L. Douw
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Non-invasively measured brain activity is related to progression-free survival in glioma patients, suggesting its potential as a marker of glioma progression. We therefore assessed the relationship between brain activity and increasing tumor
Externí odkaz:
https://doaj.org/article/db7a744192a044f1a2cdce3407df8c2d
Autor:
L. Bleeker, M. C. M. Kouwenhoven, I. de Heer, B. I. Lissenberg-Witte, A. H. Gijsbers, H. J. Dubbink, J. M. Kros, J. M. M. Gijtenbeek, E. Kurt, C. C. D. van der Rijt, A. T. Swaak-Kragten, F. Y. de Vos, H. L. van der Weide, P. J. French, M. J. van den Bent, P. Wesseling, J. E. C. Bromberg
Publikováno v:
Journal of Neuro-Oncology, 162, 1, pp. 225-235
Journal of Neuro-Oncology, 162, 225-235
JOURNAL OF NEURO-ONCOLOGY, 162. SPRINGER
Journal of Neuro-Oncology, 162(1), 225-235. Kluwer Academic
Journal of Neuro-Oncology, 162(1), 225-235. Kluwer Academic Publishers
Bleeker, L, Kouwenhoven, M C M, de Heer, I, Lissenberg-Witte, B I, Gijsbers, A H, Dubbink, H J, Kros, J M, Gijtenbeek, J M M, Kurt, E, van der Rijt, C C D, Swaak-Kragten, A T, de Vos, F Y, van der Weide, H L, French, P J, van den Bent, M J, Wesseling, P & Bromberg, J E C 2023, ' Medulloblastoma in adults : evaluation of the Dutch society for neuro-oncology treatment protocol ', Journal of Neuro-Oncology, vol. 162, no. 1, pp. 225-235 . https://doi.org/10.1007/s11060-023-04285-8
Journal of Neuro-Oncology, 162, 225-235
JOURNAL OF NEURO-ONCOLOGY, 162. SPRINGER
Journal of Neuro-Oncology, 162(1), 225-235. Kluwer Academic
Journal of Neuro-Oncology, 162(1), 225-235. Kluwer Academic Publishers
Bleeker, L, Kouwenhoven, M C M, de Heer, I, Lissenberg-Witte, B I, Gijsbers, A H, Dubbink, H J, Kros, J M, Gijtenbeek, J M M, Kurt, E, van der Rijt, C C D, Swaak-Kragten, A T, de Vos, F Y, van der Weide, H L, French, P J, van den Bent, M J, Wesseling, P & Bromberg, J E C 2023, ' Medulloblastoma in adults : evaluation of the Dutch society for neuro-oncology treatment protocol ', Journal of Neuro-Oncology, vol. 162, no. 1, pp. 225-235 . https://doi.org/10.1007/s11060-023-04285-8
Purpose Medulloblastoma is a rare tumor in adults. The objective of this nationwide, multicenter study was to evaluate the toxicity and efficacy of the Dutch treatment protocol for adult medulloblastoma patients. Methods Adult medulloblastoma patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67427e41dff228838387fb83cfe695a8
Autor:
P B van der Meer, L Dirven, M Fiocco, M J Vos, M C M Kouwenhoven, M J van den Bent, M J B Taphoorn, J A F Koekkoek
Background About 10% of the glioma patients need antiepileptic drug (AED) tripletherapy due to refractory epilepsy. This study aimed to determine whether levetiracetam combined with valproic acid and clobazam (LEV+VPA+CLB), a commonly prescribed trip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728ce6a76e2061453ce6f10e30d09971
https://hdl.handle.net/1887/3503886
https://hdl.handle.net/1887/3503886
Autor:
M R van Lingen, L C Breedt, A Hillebrand, M Klein, M C M Kouwenhoven, J C Reijneveld, P C De Witt Hamer, M L M Zimmermann, F A N Santos, L Douw
Publikováno v:
Neuro-Oncology. 24:ii25-ii26
Background Many patients with glioma suffer from deficits in executive functioning (EF), regardless of tumor location and size. While some patients experience improving EF after tumor resection, others deteriorate over time. This variability in cogni
Autor:
J. M. Niers, M. A. van de Wiel, Johan M. Kros, M. C. M. Kouwenhoven, H. F. van Thuijl, Wies Vallentgoed, Pim J. French, Pieter Wesseling, I. Martin, M. J. van den Bent
Publikováno v:
Neuro Oncol
BACKGROUND The evolutionary processes that drive progression in patients with IDH-mutant astrocytoma remain unclear. The GLASS-NL consortium, as part of the larger worldwide GLASS consortium, was initiated to gain insight into the molecular mechanism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa3bf027ace174fccc4c3ac5d8d6f417
https://europepmc.org/articles/PMC8427387/
https://europepmc.org/articles/PMC8427387/
Autor:
M. C. M. Kouwenhoven, Martin Klein, C. W. Samuels, Dieta Brandsma, Anja Gijtenbeek, Frank J. Lagerwaard, Pieter Wesseling, P. C. de Witt Hamer, M. C. J. Hanse, Angelique Sijben, Marion Smits, Marjolein Geurts, B. Idema, Maaike J. Vos, Martinus P.G. Broen, Annemieke M E Walenkamp, S. K. Polman, M. E. De Swart, Vincent K Y Ho, Tatjana Seute, Pim J. French, Johan A F Koekkoek
Publikováno v:
Neuro-Oncology. 23:ii44-ii44
BACKGROUND Delay in cancer care may adversely affect emotional distress, treatment outcome and survival. Optimal timings in multidisciplinary glioblastoma care are a matter of debate and clear national guidelines only exist for time to neurosurgery.
Autor:
Vincent K Y Ho, Marjolein Geurts, S. K. Polman, P. C. de Witt Hamer, Angelique Sijben, Pieter Wesseling, Anja Gijtenbeek, Frank J. Lagerwaard, M. E. De Swart, B. Idema, Tatjana Seute, Johan A F Koekkoek, M. C. M. Kouwenhoven, Pim J. French, Annemieke M E Walenkamp, C. W. Samuels, Marion Smits, Dieta Brandsma, Maaike J. Vos, Martinus P.G. Broen, Martin Klein, M. C. J. Hanse
Publikováno v:
Neuro-Oncology. 23:ii46-ii46
BACKGROUND Over the past years, increasing worldwide attention towards centralization of complex cancer care has been pursued as higher volume centers have shown improved outcomes. Changes in distribution of care and the impact on travel distance in
Autor:
Laila Poisson, M C M Kouwenhoven, James Snyder, Kristin Alfaro-Munoz, Manpreet Kaur, Amanda Bates, Roel Verhaak, Colin Watts, Gelareh Zadeh, D Ryan Ormond, Elizabeth Claus, Mustafa Khasraw
Publikováno v:
Neuro Oncol
As an uncommon cancer, clinical and translational studies of glioma rely on multi-center collaborations, confirmatory studies, and meta-analyses. Unfortunately, interpretation of results across studies is hampered by the absence of uniformly coded cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7e88aede48316d6794f81676befbf39
https://europepmc.org/articles/PMC6847827/
https://europepmc.org/articles/PMC6847827/
Autor:
Johan M. Kros, M C M Kouwenhoven, Winand N.M. Dinjens, Martin J B Taphoorn, Roelien H. Enting, Alba A. Brandes, Khê Hoang-Xuan, on behalf Eortc investigators, Thierry Gorlia, Martin J. van den Bent, Hans J.J.A. Bernsen, Jean-Yves Delattre, Marc Frenay, Michael Weller, Pim J. French, Nathalie E. Synhaeve, Vassilis Golfinopoulos
Publikováno v:
Neuro Oncol
BACKGROUND Between 1995 and 2002 the EORTC Brain Tumor Group conducted a prospective phase III study on adjuvant procarbazine, CCNU and vincristine (PCV) chemotherapy in anaplastic oligodendroglioma (AOD). A mature follow-up presented in 2012 showed